Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Cash Equivalents | 0.07 | 0.00 | 0.03 | 0.05 |
Cashand Short Term Investments | 0.07 | 0.00 | 0.03 | 0.05 |
Accounts Receivable- Trade Net | 1.34 | - | - | - |
Total Receivables Net | 1.34 | - | - | - |
Total Current Assets | 1.41 | 0.00 | 0.03 | 0.05 |
Note Receivable- Long Term | 0.00 | 0.00 | 0.05 | 0.05 |
Other Long Term Assets Total | 0.11 | 0.11 | 0.11 | 0.11 |
Total Assets | 1.52 | 0.11 | 0.18 | 0.21 |
Other Currentliabilities Total | 1.39 | 0.09 | 1.58 | 1.52 |
Total Current Liabilities | 1.39 | 0.09 | 1.58 | 6.09 |
Long Term Debt | 4.57 | 4.33 | 4.93 | - |
Total Long Term Debt | 4.57 | 4.33 | 4.93 | 0.00 |
Total Debt | 4.57 | 4.33 | 4.93 | 4.57 |
Total Liabilities | 5.95 | 4.42 | 6.50 | 6.09 |
Common Stock Total | 10.00 | 10.00 | 10.00 | 10.00 |
Retained Earnings( Accumulated Deficit) | -14.44 | -14.30 | -16.32 | -15.88 |
Total Equity | -4.44 | -4.30 | -6.32 | -5.88 |
Total Liabilities Shareholders' Equity | 1.52 | 0.11 | 0.18 | 0.21 |
Total Common Shares Outstanding | 1.00 | 1.00 | 1.00 | 1.00 |
Tangible Book Valueper Share Common Eq | -4.44 | -4.30 | -6.32 | -5.88 |
Notes Payable/ Short Term Debt | - | 0.00 | 0.00 | 0.00 |
Current Portof LT Debt/ Capital Leases | - | 0.00 | 0.00 | 4.57 |
Cash | - | - | 0.00 | 0.00 |
Roselabs Finance Dividend Roselabs Finance Bonus Roselabs Finance News Roselabs Finance AGM Roselabs Finance Rights Roselabs Finance Splits Roselabs Finance Board Meetings Roselabs Finance Key Metrics Roselabs Finance Shareholdings Roselabs Finance Profit Loss Roselabs Finance Cashflow Roselabs Finance Q1 Results Roselabs Finance Q2 Results Roselabs Finance Q3 Results Roselabs Finance Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks